The background of mitochondrial DNA haplogroup J increases the sensitivity of Leber's hereditary optic neuropathy cells to 2,5-hexanedione toxicity.
Leber's hereditary optic neuropathy (LHON) is a maternally inherited blinding disease due to mitochondrial DNA (mtDNA) point mutations in complex I subunit genes, whose incomplete penetrance has been attributed to both genetic and environmental factors. Indeed, the mtDNA background defined as haplogroup J is known to increase the penetrance of the 11778/ND4 and 14484/ND6 mutations. Recently it was also documented that the professional exposure to n-hexane might act as an exogenous trigger for LHON. Therefore, we here investigate the effect of the n-hexane neurotoxic metabolite 2,5-hexanedione (2,5-HD) on cell viability and mitochondrial function of different cell models (cybrids and fibroblasts) carrying the LHON mutations on different mtDNA haplogroups. The viability of control and LHON cybrids and fibroblasts, whose mtDNAs were completely sequenced, was assessed using the MTT assay. Mitochondrial ATP synthesis rate driven by complex I substrates was determined with the luciferine/luciferase method. Incubation with 2,5-HD caused the maximal loss of viability in control and LHON cells. The toxic effect of this compound was similar in control cells irrespective of the mtDNA background. On the contrary, sensitivity to 2,5-HD induced cell death was greatly increased in LHON cells carrying the 11778/ND4 or the 14484/ND6 mutation on haplogroup J, whereas the 11778/ND4 mutation in association with haplogroups U and H significantly improved cell survival. The 11778/ND4 mutation on haplogroup U was also more resistant to inhibition of complex I dependent ATP synthesis by 2,5-HD. In conclusion, this study shows that mtDNA haplogroups modulate the response of LHON cells to 2,5-HD. In particular, haplogroup J makes cells more sensitive to its toxic effect. This is the first evidence that an mtDNA background plays a role by interacting with an environmental factor and that 2,5-HD may be a risk element for visual loss in LHON. This proof of principle has broad implications for other neurodegenerative disorders such as Parkinson's disease.
Ghelli
Anna
A
Dipartimento di Biologia Evoluzionistica Sperimentale, Università di Bologna, Bologna, Italy. annamaria.ghelli@unibo.it
Porcelli
Anna Maria
AM
Zanna
Claudia
C
Vidoni
Sara
S
Mattioli
Stefano
S
Barbieri
Anna
A
Iommarini
Luisa
L
Pala
Maria
M
Achilli
Alessandro
A
Torroni
Antonio
A
Rugolo
Michela
M
Carelli
Valerio
V
D000255:Adenosine Triphosphate / Q000737:chemistry / Q000378:metabolism; D002470:Cell Survival; D004272:DNA, Mitochondrial / Q000235:genetics* / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006239:Haplotypes; D006588:Hexanones / Q000633:toxicity*; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D008957:Models, Genetic; D009154:Mutation; D029242:Optic Atrophy, Hereditary, Leber / Q000188:drug therapy / Q000235:genetics*; D016133:Polymerase Chain Reaction; D017422:Sequence Analysis, DNA; D013778:Tetrazolium Salts / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology; D014050:Toluene / Q000494:pharmacology
D004272:DNA, Mitochondrial; D006588:Hexanones; D013778:Tetrazolium Salts; D013844:Thiazoles; D014050:Toluene; D000255:Adenosine Triphosphate; C011269:2,5-hexanedione; C022616:thiazolyl blue